Role of serotonin2C receptors in the control of brain dopaminergic function

Pharmacology Biochemistry and Behavior

Volumn 71, Issue 4, 2002, Pages 727-734

  Di Matteo, Vincenzo ^a   Cacchio, Marisa ^b   Di Giulio, Camillo ^b   Esposito, Ennio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

5 HT2C receptors; Antidepressants; Antipsychotics; Dopaminergic function; Mesolimbic system; Nigrostriatal system

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; FLUOXETINE; MIANSERIN; NEUROLEPTIC AGENT; RECEPTOR SUBTYPE; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; ELECTROPHYSIOLOGY; LIMBIC SYSTEM; NEUROPSYCHIATRY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

EID: 0036125178     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00705-5     Document Type: Review

References (48)

1. 2C receptor protein in human and rat brain using specific antisera
2. Levodopa: Is toxicity a myth?
3. The functional anatomy of basal ganglia disorders
4. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat
5. A review of central 5-HT receptors and their function
6. 2 receptor subtypes: A family reunited?
7. Molecular biology of 5-HT receptors
8. Dopamine and depression
9. Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the forced swimming test by enhancing dopamine mechanisms in the nucleus accumbens
10. Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophrenia
11. 2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: A combined in vivo electrophysiological and microdialysis study
12. 2C/2B receptor agonists: A combined in vivo electrophysiological and microdialysis study
13. m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors
14. The degree of inhibition of dopaminergic neurons in the ventral tegmental area induced by selective serotonin reuptake inhibitors is a function of the density-power-spectrum of the interspike interval
15. 2C/2B receptors enhances dopamine release in the rat nucleus accumbens
16. 2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system
17. 2C receptors
18. 2C receptors
19. 2C receptor messenger RNA in the basal ganglia of adults rats
20. Neurobiology of depression: Focus on dopamine
21. 2C receptor binding is increased in the substantia niga pars reticulata in Parkinson's disease
22. 2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
23. 2C receptors on cocaine and food maintained behavior
24. 2C receptors reduces the locomotor and rewarding effects of nicotine
25. 2 receptor agonists
26. Parkinson's disease: Prospects for improved drug therapy
27. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors
28. Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons
29. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
30. 2C/2B receptor antagonists: Neurochemical and behavioural studies
31. 1C receptors and antidepressants
32. B synaptic potential in rat dopamine neurons
33. 2B receptor antagonist with anxiolytic-like properties
34. 2C receptor antagonist
35. Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations
36. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo
37. Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression
38. Quantitative and morphometric data indicate precise cellular interactions between serotonin and postsynaptic targets in rat substantia nigra
39. Quantitative autoradiographic mapping of serotonin receptors in the rat brain: I. Serotonin-1 receptors
40. 2C receptors
41. Differential effects of acute and chronic flouxetine administration on the spontaneous activity of dopaminergic neurons in the ventral tegmental area
42. Serotonin-dopamine interaction in the rat ventral tegmental area: An electrophysiological study in vivo
43. 2 receptors in adult rat brain after destruction of nigrostriatal dopamine neurons: A quantitative autoradiographic study
44. Subthalamic nucleus-mediated excitoxicity in Parkinson's disease: A target for neuroprotection
45. Reversal of antidepressant action by dopamine antagonists in an animal model of depression
46. 2C receptors in modifying ethanol self-administration behaviour
47. 2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens
48. Animal models of depression: Validity and applications